Campaigns

Taking the pulse of the NHS for Stroke and Atrial Fibrillation

Taking the pulse of the NHS for Stroke and Atrial Fibrillation To read the full report go to the publications section of the web site

Read more »

Take Action Now - ­ Action Plan

The Action Plan published today was developed by AntiCoagulation Europe (ACE) in partnership with Stroke Alliance for Europe (SAFE), the AF Association and Arrhythmia Alliance and as a guide to campaigning for the effective management of AF patients at risk of stroke. Click here to learn how your advocacy can make use of the Action Plan.

Read more »

New anticoagulation alliance calls for greater choice for patients to self-monitor The countdown starts to the launch of a new campaign aimed at giving long-term warfarin patients greater choice in the management of their condition. The campaign will be launched in the House of Commons on the 24th October 2012.

The AntiCoagulation Self-Monitoring Alliance (ACSMA) is launching a new campaign with the specific objective of achieving greater access via prescription to INR self-monitoring technology for patients receiving warfarin therapy. The alliance is also seeking to raise awareness of the benefits of self-monitoring and aims to ensure that patients are equipped to have informed discussions with their healthcare professionals on this topic.

Read more »

UK on brink of a stroke crisis

New Report Confirms UK is on the Brink of a Stroke Crisis Critical Action Steps Outlined to Reduce Strokes Caused by Atrial Fibrillation AntiCoagulation Europe, as a leading member of an alliance of renowned health experts and patient organisations, calls for policy makers and the medical and patient communities to collectively act to prevent strokes that strike thousands of people with atrial fibrillation (AF) each year. A major report published today outlines critical action steps to rduce strokes casued by atrial fibrillation. The report is available on the publications page.

Read more »

Join the mission on World Heart Day 2012: call for signatures Sign the 1 Mission 1 Million petition to alert health organizations to the devastating strokes caused by an irregular heart rhythm

To mark World Heart Day (29.09.12), the awareness initiative “1 Mission 1 Million – Getting to the Heart of Stroke” is calling on millions of people to join together and raise awareness of the irregular heart rhythm atrial fibrillation by signing a global petition: www.heartofstroke.com/Petition. Since many people are not aware of the increased risk of stroke associated with atrial fibrillation, more needs to be done to raise awareness of this serious condition and ensure it is appropriately managed.

Read more »

The sAFe Report

Urgent improvements needed for up to 1 million patients with atrial fibrillation (AF) Experts call for better management of this life-threatening condition A report launched by ACE and written by UK experts shows that atrial fibrillation (AF), a condition that affects up to 1 million people in the UK, is not being optimally managed. The report warns that UK GPs are often prescribing aspirin for stroke prevention in patients with AF, including those eligible for anticoagulation, despite clinical evidence demonstrating that stroke protection provided by anticoagulant therapies is far superior.

Read more »

1 Mission 1 Million launch of campaign to collect 1 Million signatures

1 Mission 1 Million to collect 1 million signatures to call upon the World Health Organisation to save lives through education and improve management of atrial fibrillation

Read more »

Abolition of prescription charges

Some time ago we started to ask Government to review the existing Prescriptions Exemptions list with the aim to include anticoagulation therapy in the list.

Read more »

Major report on Atrial Fibrillation launched by ACE.

A major source of information for patients and healthcare professionals on all aspects of AF, including urgent actions needed now to prevent untreated AF from causing a stroke epidemic.
Read the AF Report
Calculate your personal risk of stroke because of AF

Read more »

NICE Recommends Xarelto® (rivaroxaban) as a Single-Drug Therapy for Deep Vein Thrombosis (DVT) and Prevention of Recurrent DVT and Pulmonary Embolism (PE) after an Acute DVT in Adult Patients

Read more »

AntiCoagulation Europe, PO Box 405, Bromley, Kent BR2 9WP. Registered Charity: 1090250
Privacy | Terms & Conditions © Anticoagulation Europe 2011
Web design by Bright White Space